🇺🇸 FDA
Patent

US 7662780

Administering hypocretin to obese individuals

granted A61KA61K38/22

Quick answer

US patent 7662780 (Administering hypocretin to obese individuals) held by The Regents of the University of California expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/22